Status:
UNKNOWN
PREcision Medicine in Cancer in Odense, Denmark
Lead Sponsor:
Odense University Hospital
Conditions:
Metastatic Solid Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The traditional approach to cancer treatment has changes from using drugs approved for the specific cancer diagnosis to a tumor agnostic approach when treating solid tumors. How often will tumor biops...
Detailed Description
Genomic profiling in patients with advanced solid tumors and no further evidence based treatment options is a newer approach. The frequency of genomic alterations varies between individual tumor types...
Eligibility Criteria
Inclusion
- Written informed consent
- Age ≥ 18 years
- Diagnosis of advanced solid tumors
- Evidence based treatment options are exhausted
- Performance Status 0-2
- Adequate organ function
- Life expectancy of at least 3 months
Exclusion
- • inclusions criteria not met
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT05385081
Start Date
March 1 2019
End Date
December 31 2023
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense Universitets Hospital dept of oncology
Odense C, Denmark, 5000